Aqueous formulations of parasiticides for skin applications
DCFirst Claim
Patent Images
1. A water-containing formulation for the dermal control of parasitic insects on animals by means of agonists or antagonists of the nicotinic acetylcholine receptors of insects, comprising:
- a) agonists or antagonists of the nicotinic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation, wherein the agonists or antagonists are selected from one or more compounds of formula (I)
3 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The present invention relates to water-containing formulations for the dermal control of parasitic insects on animals, having the following composition
- a) agonists or antagonists of the nicotinic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation;
- b) water in a concentration of from 2.5 to 15% by weight;
- c) solvents from the group alcohols such as benzyl alcohol, tetrahydrofuryl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the formulation;
- d) solvents from the group of the cyclic carbonates or lactones in a concentration of from 5 to up to 50% by weight based on the overall weight of the formulation;
- e) if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation.
7 Citations
6 Claims
-
1. A water-containing formulation for the dermal control of parasitic insects on animals by means of agonists or antagonists of the nicotinic acetylcholine receptors of insects, comprising:
a) agonists or antagonists of the nicotinic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation, wherein the agonists or antagonists are selected from one or more compounds of formula (I) - View Dependent Claims (2, 3, 4, 5, 6)
Specification